Ketamine Effect on Isoflurane Anesthesia
Electroencephalographic Effects of Ketamine During Isoflurane Maintenance and Recovery
1 other identifier
interventional
30
1 country
1
Brief Summary
Ketamine effect on isoflurane anesthesia This study is designed to study the effect of ketamine on isoflurane anesthesia. As both drugs are hypnotic and are used to cause sleep during surgery and other painful procedures, it was long believed that the actions of two drugs add to each other. For example if a man received both drugs, this man will become awake from anesthesia much later than if this man was given either of them alone. However recent studies showed that this is not the case and ketamine can cause fast recovery from hypnotic effects of isoflurane. This was confirmed in animals. The aim of current study is to investigate if this effect applies for humans, using a state of art brain monitoring device in wide use nowadays called BIS or bispectral index. This device can also shed some light on how ketamine can cause, if any, fast recovery from isoflurane anesthesia. Simply, by studying electrical wave coming from brain to head skin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Sep 2017
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2017
CompletedFirst Posted
Study publicly available on registry
September 25, 2017
CompletedStudy Start
First participant enrolled
September 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 25, 2017
CompletedNovember 28, 2017
November 1, 2017
2 months
September 8, 2017
November 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
recovery time
recovery time in this study is defined as time between stop of isoflurane inhalation and recovery of consciousness . this will be assessed by calling the patient first name loudly until the patient verbally respond.time will be recorded in seconds.
Time Frame: 1 hour
Secondary Outcomes (2)
gamma wave activity
Time Frame: 2 hour
processed EEG parameters
Time Frame: 2 hour
Study Arms (2)
isonly
ACTIVE COMPARATORThis arm will receive spinal anesthesia. then this arm will receive saline during isoflurane anesthesia. this arm will serve as a control group.
isoket
ACTIVE COMPARATORthis arm will receive spinal anesthesia. then will receive isoflurane inhalation. during isoflurane inhalation, this arm will receive single injection of ketamine. at end of anesthesia, effect of ketamine on recovery will be monitored.
Interventions
ketamine hydrochloride 250microgram/ ml for iv injection after 30 minutes of stable isoflurane anesthesia
a similar volume of normal saline 0.9% for intravenous injection instead of ketamine will be given to the control group. this because the attending anesthesiologist will be blinded to the study drugs and aim according to the study proposal.
Eligibility Criteria
You may qualify if:
- Consent: patient must be legally fit to consent. Informed consent will be get from each patient.
- ASA status: I or II.
- Fully conscious at time of induction of anesthesia.
- No history of side effects related to any drugs used in the study.
- Planned surgery can be performed under spinal anesthesia
You may not qualify if:
- Incompetence: failure to give informed consent or refusal.
- Neurological or psychiatric disorders
- Addiction
- Recent intake of drugs affecting central nervous system
- ASA state more than II
- Morbid obesity
- Surgery cannot solely performed under spinal anesthesia
- Contraindication to spinal anesthesia as coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Minia University Hospital (main hospital)-kornish elnil st.
Minya, Minya Governorate, 61511, Egypt
Related Publications (5)
Li D, Hambrecht-Wiedbusch VS, Mashour GA. Accelerated Recovery of Consciousness after General Anesthesia Is Associated with Increased Functional Brain Connectivity in the High-Gamma Bandwidth. Front Syst Neurosci. 2017 Mar 24;11:16. doi: 10.3389/fnsys.2017.00016. eCollection 2017.
PMID: 28392760BACKGROUNDMashour GA. Cognitive unbinding: a neuroscientific paradigm of general anesthesia and related states of unconsciousness. Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2751-9. doi: 10.1016/j.neubiorev.2013.09.009. Epub 2013 Sep 26.
PMID: 24076246BACKGROUNDPhilip BK, Kallar SK, Bogetz MS, Scheller MS, Wetchler BV. A multicenter comparison of maintenance and recovery with sevoflurane or isoflurane for adult ambulatory anesthesia. The Sevoflurane Multicenter Ambulatory Group. Anesth Analg. 1996 Aug;83(2):314-9. doi: 10.1097/00000539-199608000-00019.
PMID: 8694311BACKGROUNDCampbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ. 1995 Oct 28;311(7013):1145-8. doi: 10.1136/bmj.311.7013.1145.
PMID: 7580713BACKGROUNDFlorey CD. Sample size for beginners. BMJ. 1993 May 1;306(6886):1181-4. doi: 10.1136/bmj.306.6886.1181.
PMID: 8499826BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mamdouh H Hassan, MD
Minia faculty of Medicine. Minia university. Egypt
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The patients well be randomized to one of the two groups by closed envelope technique. After opening the envelope, the study drug (ketamine 100µg/kg total body weight (Isoket group)) or normal saline ((Isonly) or control group) will be prepared, made up to 10 ml and administered by an assistant in the proper timing. The patient identification will be written on a slip and put back into an envelope and sealed. The person doing the procedure and monitoring along with the patient will be blinded to the dose and nature of solution. The equal volume test solution will be given intravenously by an assistant who was not involved in the administration of anesthesia and monitoring
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia and intensive care
Study Record Dates
First Submitted
September 8, 2017
First Posted
September 25, 2017
Study Start
September 30, 2017
Primary Completion
November 15, 2017
Study Completion
November 25, 2017
Last Updated
November 28, 2017
Record last verified: 2017-11